Kelly Davis, NP
Women's Health · Chesapeake, VANPI 1609994151
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$397
- AbbVie$342
- Organon$314
- Sumitomo Pharma America, Inc.$288
- Myovant Sciences Inc.$188
- Bayer$187
- plus $868 from 17 others
What the payments were for
- Food & beverage$2,584100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 26 | $397 |
| AbbVie | 29 | $342 |
| Organon | 17 | $314 |
| Sumitomo Pharma America, Inc. | 18 | $288 |
| Myovant Sciences Inc. | 13 | $188 |
| Bayer | 10 | $187 |
| Astellas Pharma US Inc | 7 | $150 |
| Xeris Pharmaceuticals, Inc. | 1 | $106 |
| Shield Therapeutics Inc | 5 | $89 |
| Evofem Biosciences, Inc. | 4 | $82 |
| Hologic Sales And Service, LLC | 4 | $66 |
| Optumhealth Care Solutions, LLC | 3 | $59 |
| Agile Therapeutics, Inc. | 3 | $40 |
| Merck | 2 | $37 |
| Aspira Women's Health Inc | 2 | $36 |
| Mayne Pharma Commercial LLC | 2 | $35 |
| Millicent US Inc | 2 | $35 |
| Pfizer | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $26 |
| Virtus Pharmaceuticals LLC | 1 | $25 |
| Scynexis, Inc. | 1 | $20 |
| Lupin Inc. | 1 | $17 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEVEYIS$106
How this compares
$2,584 in reported general payments places this provider in the 90th percentile of 188 women's health providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 11 | $598 |
| Estradiol | 27 | $348 |
| Medroxyprogesterone Acetate | 15 | $181 |
Paid to pharmacies, not to this prescriber.
Other women's health in Chesapeake
- Melody TappChesapeake$2K
- Emma McClainChesapeake$943
- Claire SenecalChesapeake$843
- Heather PayneCharlottesville$28K
- Heather HallbergVirginia Beach$27K
- Whitney CottonVirginia Beach$14K
- Kara ParkerRichmond$10K
- Jenifer CotterVirginia Beach$6K
- Jessica JohnsonHampton$3K
- Elizabeth LambRichmond$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.